Finance > Venture Deals Database > Venture Transactions Database > Monthly Deals (All) > August 2022 VC Transactions
InSilico Medicine

Tech Company Financing Transactions

InSilico Medicine Funding Round

InSilico Medicine closed a $95 million Series D venture capital round on 8/11/2022. Investors included Prosperity7 Ventures, B Capital Group and BHR Partners.

Transaction Overview

Company Name

InSilico Medicine

Announced On

8/11/2022

Transaction Type

Venture Equity

Amount

$95,000,000

Round

Series D

Investors

Prosperity7 Ventures (Lead Investor)

B Capital Group

BHR Partners

Bold Capital Partners

Deerfield Management Company

private investors (Alex Zhavoronkov)

Pavilion Capital Partners

Qiming Ventures (Nisa Leung)

Warburg Pincus (Min Fang)

WS Investment

Proceeds Purpose

The company intends to use the funds for the continued advancement of its pipeline, including its lead program which is currently in a Phase 1 study in New Zealand and in China, as well as several pipeline programs in IND-enabling studies, further development of its end-to-end Pharma.AI platform, launch of a fully automated, AI-driven robotic drug discovery laboratory and biological data factory, and the establishment of regional centers.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Core Building 1 1 Science Park East Ave.Hong Kong Science Pa 307A
Hong Kong, 00000
Hong Kong

Phone

Undisclosed

Website

www.insilicomedicine.com

Email Address

[email protected]

Overview

Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research. We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare, and anti-aging interventions.

Profile

Social Media

InSilico Medicine Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alex Zhavoronkov

Chief Operating Officer

Qingsong Zhu

Chief Scientific Officer

Jimmy Lin

Chief Technical Officer

Alex Zhebrak

President

Alex Aliper

Browse more venture capital transactions:

Prev: 8/11/2022: Mesh Security venture capital transaction
Next: 8/11/2022: Invisible Universe venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary